ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,859Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 96

$1.06M Total Retail Price of All Prescriptions

Rank: 7 out of 96

522 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 522 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 522 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 11,591 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 489 302 1 2
SIMVASTATIN 470 403 2 1
FUROSEMIDE 436 366 3 4
LEVOTHYROXINE SODIUM 355 315 4 3
OMEPRAZOLE 348 259 5 5
ENDOCET 335 109 S2 6 94
ZOLPIDEM TARTRATE 298 143 7 18
CARVEDILOL 275 231 8 22
DONEPEZIL HCL 266 255 9 8
OXYCODONE-ACETAMINOPHEN 254 149 S2 10 26
CRESTOR 249 144 11 39
GLIMEPIRIDE 236 165 12 43
ATORVASTATIN CALCIUM 229 169 13 12
METFORMIN HCL 215 144 14 13
METOPROLOL TARTRATE 214 187 15 7
DIOVAN 212 187 16 17
JANUVIA 179 99 17 49
SODIUM CHLORIDE 164 164 18 167
HYDROCODONE-ACETAMINOPHEN 162 80 S3 19 52
NEXIUM 162 91 19 40
NAMENDA 161 161 21 11
PROAIR HFA 151 39 22 72
LISINOPRIL 149 107 23 10
DIOVAN HCT 149 113 23 64
ADVAIR DISKUS 149 70 23 46
METOPROLOL SUCCINATE 148 110 26 9
AMLODIPINE BESYLATE-BENAZEPRIL 147 116 27 105
GABAPENTIN 147 87 27 20
CLONIDINE HCL 144 88 29 74
WARFARIN SODIUM 136 118 30 6
CITALOPRAM HBR 135 135 31 25
FAMOTIDINE 134 96 32 21
CEFUROXIME 133 91 33 155
POTASSIUM CHLORIDE 132 103 34 19
BYSTOLIC 131 68 35 56
MIRTAZAPINE 128 122 36 14
QUETIAPINE FUMARATE 125 99 37 32
TRAMADOL HCL 119 84 38 35
MELOXICAM 119 92 38 65
CLOPIDOGREL 117 105 40 27
RANITIDINE HCL 111 88 41 75
ESCITALOPRAM OXALATE 106 75 42 24
GLIPIZIDE 105 73 43 62
ATENOLOL 105 102 43 30
PROMETHAZINE HCL 104 40 R 45 163
PRAVASTATIN SODIUM 104 92 45 33
PLAVIX 102 82 47 42
LEVOFLOXACIN 93 73 48 59
ENALAPRIL MALEATE 91 54 49 28
LOSARTAN POTASSIUM 91 81 49 23
CYCLOBENZAPRINE HCL 90 61 R 51 175
TAMSULOSIN HCL 90 66 51 29
AZITHROMYCIN 88 30 53 54
ALENDRONATE SODIUM 87 81 54 36
FLUTICASONE PROPIONATE 85 41 55 55
POLYETHYLENE GLYCOL 3350 83 73 56 53
LACTULOSE 82 75 57 37
TRAMADOL HCL-ACETAMINOPHEN 81 61 58 81
CARBIDOPA-LEVODOPA 78 78 59 48
ISOSORBIDE MONONITRATE ER 75 75 60 60
LANTUS 75 55 60 68
BACLOFEN 74 50 62 108
MECLIZINE HCL 73 58 63 134
GLIPIZIDE XL 69 57 64 161
SERTRALINE HCL 68 50 65 15
LANTUS SOLOSTAR 68 41 65 87
AMMONIUM LACTATE 67 51 67 152
METOCLOPRAMIDE HCL 66 63 68 190
ACETAMINOPHEN-CODEINE 66 31 S3 68 113
CLOTRIMAZOLE-BETAMETHASONE 65 37 70 101
OXYCONTIN 64 13 S2 71 118
RISPERIDONE 63 56 72 31
TRAVATAN Z 62 61 73 79
ALLOPURINOL 62 62 73 82
SANTYL 61 61 75 71
LOVAZA 61 35 75 102
DIVALPROEX SODIUM 60 60 77 41
ATENOLOL-CHLORTHALIDONE 59 47 78 247
PREDNISONE 58 42 79 58
TRAZODONE HCL 58 41 79 38
DIGOXIN 57 54 81 34
PAROXETINE HCL 56 52 82 66
IBUPROFEN 56 13 82 138
LATANOPROST 56 56 82 77
AMITRIPTYLINE HCL 54 30 R 85 258
SINGULAIR 51 31 86 78
LYRICA 51 37 86 73
LEVETIRACETAM 51 42 86 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.